Found 6 matching trials
MK0457 (an Aurora Kinase Inhibitor) Study in Patients With Advanced Colorectal Cancer and Other Advanced Solid Tumors (0457-001) PHASE1 Study with an investigational drug in patients with recurrent or non-respon...
Show More Location
Multiple Locations
Learn More & Join Trial
A VX-680 (an Aurora Kinase Inhibitor) Study in Patients With Advanced Cancer (0457-002) PHASE1 The purpose of this study is to assess the safety and tolerability of MK-04...
Show More Location
Multiple Locations
Learn More & Join Trial
A Phase I Dose Escalation Combination Study in Patients With Chronic Myelogenous Leukemia (CML) and Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL)(0457-009)(TERMINATED) PHASE1 This study will evaluate MK0457 in combination with Dasatinib in patients w...
Show More Location
Multiple Locations
Learn More & Join Trial
MK0457 in Patients With Leukemia (0457-003) PHASE1 In this study participants with relapsed/refractory leukemia will be given ...
Show More Location
Multiple Locations
Learn More & Join Trial
A Phase II Study of MK0457 in Patients With T315I Mutant CML and Ph+All (0457-008) PHASE2 This study will evaluate MK0457 in patients with chronic myelogenous leukem...
Show More Location
Multiple Locations
Learn More & Join Trial
A Phase IIA Study of MK0457 in Patients With Cancer of the Lung (0457-006) PHASE2 This is a study to evaluate the effectiveness of an investigational drug in...
Show More Location
Multiple Locations
Learn More & Join Trial